Biohm is an eco-conscious bio-technology company that is revolutionising construction through nature-inspired innovation. The company has adopted methods such as circular construction system, biomimicry, and triagomy. Some of the company’s carbon-negative bio-based materials include building insulation made out of Mycelium (the root structure of mushrooms) and ORB (Organic Refuse Biocompound), a 100% natural sheet material made out of food and agricultural surplus. For its innovation, Biohm won the Waitrose and Partners Plan Plastic Prize: The Million Pound Challenge and a Power to Change grant worth £600,000 to build sustainable living premises. It has also been shortlisted as one of The United Nation’s ‘Young Champions of the Earth’. The company will use 38% of the investment to grow its team, 22% to scale Research and Development (R&D), 22% to protect its Intellectual Property (IP), and 18% for product accreditation.
days to go:
Expired
investment:
£790,700
During their stay in hospital, around 7-10% of patients attract unexpected infections. In some cases, this is caused by unclean complex surgical tools. Aspetium have developed ultrasonic washers (dubbed "uSonic") to thoroughly decontaminate expensive surgical instruments, which can be safely reused to potentially prevent easily avoidable infections.
days to go:
Expired
investment:
£151,167
'Revolution Race Cars' is the brainchild of a team of British designers, engineers, and industry specialists. The company has produced an all-new race car: Revolution A-One that challenges not only the status quo but also changes the postcode. The car is created after eighteen months of R&D, rigorous selection, and 4,000 miles of extreme testing of Revolution's suppliers and partners. The official production of Revolution A-One started in May 2019, and its sales have already been recorded in three countries. With the proceeds, the company will optimise its production cycle for future expansion.
days to go:
Expired
investment:
£392,220
Developing ultra-efficient combustion cycles by replacing a conventional engine's mechanical drivetrain with cleaner and compact electrical components. Libertine have created Free Piston Engines that can operate by using either fossil fuels, or renewable energy.
Their products have opportunities to provide benefits in numerous industries and the company has already had discussions with two large automotive firms and OEMs that are interested in utilising the technology. Libertine owns 28 patents and has distributed a license for its product, which is currently generating annual revenue growth of around 90%. Revenues in 2017 totalled £300k.
days to go:
Expired
investment:
£710,970
Advanced Blast & Ballistic Systems (ABBS) is a company that has developed globally patented systems to counteract the forces an armoured vehicle sustains when a mine or Improvised Explosive Device (IED) explodes under it. As per reports, mines and IEDs accounted for over 80% of UK and US army casualties in Iraq & Afghanistan. ABBS believes that its products can keep occupants inside a vehicle completely safe from the aforementioned explosive devices. The armoured vehicle protection market has a value of about $20 billion wherein ABBS aims to be a major contender. The company has received £2 million-plus revenues till date from Research and Development (R&D) grants in the UK, as well as, sold its products to the US Army and Israel with profits worth £145,000 in 2018 and £560,000 in 2019 respectively. It will use the investment to bring its products to more markets globally.
days to go:
Expired
investment:
£445,814
A UK based house builder specialising in the delivery of high quality, zero carbon Smart Homes in London and South of England. Verto Homes work with a select handful of experienced property investors, purchasing land sites, redeveloping and ultimately selling new build residential properties through single project, special purpose vehicles. It has developments at various stages of construction with a combined Gross Development Value of over £21m in London and the South West of England. Verto Homes is already making sustainable living a reality with the launch of their zero carbon Smart Homes and the company is now on track to become the UK’s largest sustainable house builder by 2020.
http://vertohomes.com/
days to go:
Expired
investment:
£900,000
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go:
Expired
investment:
£62,770
Polysolar aims to transform buildings and transport infrastructure into self-generating power stations by substituting conventional construction materials with solar glazing panels. Its customers include Sainsbury’s and Canary Wharf. The company estimates the crossover Building-integrated Photovoltaics (BIPV) glass market worth $4 billion and aims to be a strong contender in this segment. Polysolar successfully raised £1.3 million on Crowdcube in 2018. It is in the final stages to secure a supply & install agreement with E.ON SE. It also won tenders for installing Electric Vehicle (EV) charging hubs from South Gloucester CC and Lake District National Park Authority. The company will use the investment to commercialise the immediate and significant opportunity in EV charging solar canopies and carports.
days to go:
Expired
investment:
£1,268,410
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
days to go:
Expired
investment:
£65,004
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go:
Expired
investment:
£357,179
